Immunosyn Corp. Stock Price (OTCMKTS:IMYN)

Add to My Stocks
$0 $0 (0%) IMYN stock closing price Jul 09, 2015 (Closing)
Prev Close* : $0
Market Cap:
$0.03M
Day Low: $0
52 Week Low: $0.00
Open: $0
Volume: $0
Day High: $0
52 Week High: $0.00
Dividend:
0.00

Latest Stock Market News

Latest Articles

IMYN Stockcharts

View IMYN PE ratio, PS ratio stocks charts and compare with peers.
IMYN Chart
Note: Compare Immunosyn Corp. stock price history with the index and industry peers.

Immunosyn Corp. Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
)
PB ratio (
price to book ratio
)

Immunosyn Corp. Returns

ROE
(return on equity)

Immunosyn Corp. Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

IMYN Industry Peers

Company Price Change (%)
Pivotal Therapeutics (PVTTF)00 (0%)
Nephrogenex (NRXGQ)00 (0%)
Cytrx (CYTR)1.060.02 (1.92%)
Repros Therapeutics (RPRX)0.670.01 (1.47%)
Cytrx (CYTR)1.060.02 (1.92%)
Ampliphi Biosciences (APHB)0.870.12 (12.12%)
La Jolla Pharma (LJPC)20.950.69 (3.41%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ChemoCentryx (CCXI)11.521.03 (9.82%)
AcelRx Pharma (ACRX)3.750.3 (8.7%)
MELINTA THERAPT (MLNT)4.450.35 (8.54%)
Galectin Therapeutics (GALT)6.020.28 (4.88%)
GlycoMimetics (GLYC)14.580.67 (4.82%)
Achaogen (AKAO)4.280.17 (4.14%)
Concert Pharma (CNCE)13.420.51 (3.95%)
Top gainers from Medical-Drugs industry
* As of Sep 19, 2018
CompanyPriceChange (%)
MADRIGAL PHARMA (MDGL)207.321.13 (9.25%)
Tetraphase Pharmaceuticals (TTPH)2.90.16 (5.23%)
Recro Pharma (REPH)7.410.29 (3.77%)
Corcept Therapeutics (CORT)14.260.48 (3.26%)
Lannett Co (LCI)4.750.15 (3.06%)
Catalyst Pharma (CPRX)3.10.09 (2.82%)
Galmed Pharma (GLMD)12.610.24 (1.87%)
Top losers from Medical-Drugs industry
* As of Sep 19, 2018

Immunosyn Corp. Financial Statements

income statement2009
Net Sales or Revenues-
Net Income-2.77M
Total Operating Expense0
View Immunosyn Corp. income statement
balance sheet2009
Total Assets-
Total Liabilities3.52M
Shareholders Equity-3.51M
View Immunosyn Corp. balance sheet
cash flow statement2009
Net Increase (Decrease) in Assets Liabilities2.56M
Net Cash from (used by) Operating Activities-0.14M
Increase (Decrease) in Prop Plant And Equipment-
View Immunosyn Corp. cash flow statement

Immunosyn Corp. Stock Message Board

Immunosyn Corp. stock price ended the last trading day at $0. Immunosyn Corp. market capitalization is $0.03M and it represents the total market value of IMYN stock. Immunosyn Corp. valuation can be guaged using various valuation metrics like the price to earnings ratio.

Demand for a stock decides its stock market price. For example, if more investors want to buy IMYN stock than sell it, then Immunosyn Corp. stock price goes up. Conversely, if more investors wanted to sell IMYN stock than buy it, there would be greater supply than demand, and the stock price would fall. The volume number in Immunosyn Corp. stock quote data shows the number of shares traded. For Ex: 0 Immunosyn Corp. shares were traded as of last trading day, as seen from Immunosyn Corp. stock chart. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. Immunosyn Corp. does not pay dividends. To check the historical stock price movement, all time high, and all time low of IMYN, view Immunosyn Corp. stock price history.

Related to Immunosyn Corp. Stock Quotes

Stocks from Medical-Drugs, Immunosyn Corp. stock price history,